Print this page
 Email this page

 Connect with UMGCC on:
 Twitter
 Facebook
 YouTube

 Share this page:

Bookmark and Share

Radiation Oncology Program

Physicians and Staff

Mohan Suntha, M.D.

Mohan Suntha, M.D.

Professor and Vice Chair, Department of Radiation Oncology
Associate Director, University of Maryland Marlene and Stewart Greenebaum Cancer Center

Education and Degrees

BS: Brown University, Providence, RI
MD: Jefferson Medical College, Philadelphia, PA
Residency: University of Maryland, Department of Radiation Oncology, Baltimore, MD

Areas of Interest

Administrative Assistant

Wanda Sutton
Phone: (410) 328-2328
Fax: (410) 328-6911

Dr. Suntha's Recent Publications

  1. Rhee JG, Li D, Suntharalingam M, O’Malley BW, Guo G, Carney JP. Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein. Int J Radiat Oncol Biol Phys 2006, accepted for publication.

  2. Bangalore M, Matthews S, Suntharalingam M. Recent advances in radiation therapy for head and neck cancer. Accepted for publication, Journal for Otorhinolaryngology, 2006, in press.

  3. Hamilton JP, Sato F, Greenwald BD, Suntharalingam M, Krasna MJ, Edelman MJ, Doyle A, Berki AT, Abraham JM, Mori Y, Kan T, Mantzur C, Paun B, Wang S, Ito T, Jin Z, Meltzer SJ. Promoter methylation and response to chemotherapy and radiation in esophageal cancer. Clin Gastroenterol Hepatol 2006 Jun;4(6):701-08.

  4. Balcer-Kubiczek EK, Attarpour M, Jiang J, Kennedy AS, Suntharalingam M. Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells. Chemotherapy 2006;52(5):231-40.

  5. Li XA, O’Neil M, Suntharalingam M. Improving patient-specific dosimetry for intravascular brachytherapy. Brachytherapy 2005;4:291-97.

  6. Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen J. Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving therapy for carcinoma of the esophagus. J Clin Oncol 2005 Apr 1;23(10):2325-31.

  7. Siber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O'Neill W, Lasala J, Reisman M Sharma SK, Kuntz RE, Bonan R; START Investigators. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J 2005 Apr;149(4):689-94.

  8. Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M. An association between preoperative anemia and decreased survival in early-stage non-small cell lung cancer patients treated with surgery alone. Int J Radiat Oncol Biol Phys 2005 Aug 1;62(5):1438-43.

  9. Kwong K, Edelman MJ, Suntharalingam M, Cooper L, Gamliel Z, Burrows W, Hausner P, Doyle LA, Krasna MJ. High-dose radiation in tri-modality treatment of pancoast tumors resulting in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg 2005;129(6):1250-7.

  10. Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M. Predictors of acute esophagitis in patients with non-small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiation therapy followed by surgery. Int J Radiat Oncol Biol Phys 2004;60(4):1106-1112.

  11. Sonett JR, Suntharalingam M, Edelman MJ, Gamliel Z, Doyle A, Hausner, P, Dickerson A, Krasna MJ. Pulmonary resection following neoadjuvant high dose curative intent radiotherapy (>59Gy) and concurrent chemotherapy. Ann Thorac Surg 2004;78(4):1200-1205.

  12. Suntharalingam M, Jaboin J, Taylor R, Wolf J, Bangalore M, Van Echo D, Ord R. The evaluation of amifostine for mucosal protection in patients with advanced loc-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel and daily radiotherapy (RT). Semin Oncol 2004;31(6 Suppl 18):2-7.

  13. Suntharalingam M. The role of concurrent chemotherapy and radiation in the management of patients with squamous cell carcinomas of the head and neck. Semin Oncol 2003;30(4 Suppl 9):37-45.

  14. Brady D, Yu SZ, Koproski H, Rhee J, Kuman S, Pericle F, Suntharalingam M, Van Echo DA, Li D, O’Malley BW. Combination non-viral interleukin-2 gene therapy and external beam radiation therapy for head and neck cancer. Arch Otolaryngol Head and Neck 2003;129(6): 618-622.

  15. O’Malley BW, Li D, Carney J, Rhee J, Suntharalingam M. Molecular disruption of the MRN (95) complex induces radiation sensitivity in head and neck cancer. J of ORL 2003;65(3):144-154.

  16. Flannery TA, Suntharalingam M, Kwok Y, Koffman BH, Amin PA, Chin LS, Nichol B, Fowler B, Young B, Regine WF. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer. Lung Cancer 2003 32(3):327-333.

  17. Edelman JJ, Suntharalingam M, Krasna JJ. The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancer. Current Treat Options Oncol 2003;4:45-53.

  18. Timmerman R, Papiez L, Suntharalingam M. Extracranial stereotactic radiation delivery: expansion of technology beyond the brain. Technol Cancer Res Treat 2003:2:153-160.

  19. Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minskey BD, Owens JB. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 patterns of care study. Int J Radiat Oncol Biol Phys 2003;56(4):981-987.

  20. Suntharalingam M, Laskey WK, Tan J, Kuntz R, Bonan R. Vascular brachytherapy using a beta emitter. Diabetic Biol Phys 2003;57(2):536-542.

  21. Mao YS, Suntharalingam M, Krasna MJ. Management of late distant metastases after trimodality therapy for esophageal cancer. Ann Thorac Surg 2003;76(5):1742-1743.

  22. Li XA, Chilbani O, Greenwald B, Suntharalingam M. Radiotherapy dose pertubation of metallic esophageal stents. Int J Radiat Oncol Biol Phys 2002;54(4):1276-1285.

  23. Morino Y, Kaneda H, Fox T, Takagi A, Hassan, HM, Honda Y, Bonan R, Crocker I, Lansky AJ, Kaskey WK, Suntharalingam M, Bonneau HN, Yock PG, Fitzgerald PJ. Delivered dose and vascular response following beta radiaton for in-stent restenosis: Retrospective dosimetry and volumetric intravascular ultrasound analysis. Circulation 2002;106(18):2334-2339.

  24. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstrein PS, Massullo V, Bass T, Henderson R, Silber S, VonRottkay P, Bonan R, Ho KHK, Kuntz R. A randomized trial of 90Strontium/90Yttrium beta radiation versus placebo control for the treatment of in-stent restenosis. Circulation 2002;106(9):1090-1096.

  25. Suntharalingam M, Laskey W, Lansky AJ, Waksman R, White L, Teirstien P, Massulio VA, Rutherford B, Elman A, Kuntz RE, Popma JJ, Bonan R. START 40 investigators. Clinical and angiographic outcomes after use of 90strontium/90yttrium beta radiation for the reatment of in-stent restenosis: Results from the stents and radiation therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002;52(4):1075-1082.

  26. Yu XA, Li AX, Ma L, Chen D, Naqvi S, Shepard D, Safaraz M, Holmes T, Suntharalingam M, Mansfield CM. Clinical implementation of intensity modulated arc therapy. Int J Radiat Oncol Biol Phys 2002;53(2):453-463.

  27. Song JJ, Rhee JG, Suntharalingam M, Walsh SA, Spitz DR, Lee YJ. Role of glutaredoxin in notabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress medicated by H2O2. J of Biochem 2002;277(48):465-75.

  28. Jiao X, Sonett J, Gamliel Z, Doyle A, Scheutz J, Greenwald B, Suntharalingam M, Krasna MJ. Trimodality treatment versus surgery along for esophageal cancer. A stratified analysis with minimally invasive pre-treatment staging. J Cardiovasc Surg 2002;43(4):531-7.

  29. Li B, Yu J, Suntharalingam M, Kennedy AS, Amin PA, Chen Z, Yin R, Guo S, Han T, Wang Y, Yu N, Song G, Wong L. Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 2002;90(1):37-45.

  30. Ma L, Yu CX, Earl M, Holmes T, Safaraz M, Li XA, Shepard D, Amin PA, DiBiase S, Suntharalingam M, Mansfield CM. Optimized intensity modulated arc therapy for prostate cancer. Int J Cancer 2001;96:379-384.

  31. Jiao X, Krasna MJ, Sonett J, Gamliel Z, Suntharalingam M, Doyle A, Greenwald B. Pre-treatment of surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. Eur J Cardiothorac Surg 2001;19:880-886.

  32. Suntharalingam M. Innovations in the radiotherapy of head and neck cancer. Veterans Health System Journal 2001;6(3):54-58.

  33. Suntharalingam M, Haas M, Sonett J, Doyle LA, Hausner PF, Scheutz, J, Greenwald B, Krasna MJ. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Ca J Sci Am 2001;7(6):509-511.

  34. Li XA, Suntharalingam M. Dosimetry of source stepping for intravascular brachytherapy. Cardiovasc Radiat Med 2001;2(3):165-172.

  35. Lee YC, Chen JC, Amoscato AA, Bennouna J, Spitz DR, Suntharalingam M, Rhee JG. Protective role of bcl-2 in metabolic oxidative stress-induced cell death. J Cell Sci 2001;114(4):677-684.

  36. Suntharalingam M, Haas ML, VanEcho DA, Haddad R, Jacobs MC, Levy S, Gray WC, Ord RA, Conley BA. Predictors of response and survival following concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer 2001;91:448-554.

  37. Suntharalingam M. Radiation therapy for esophageal cancer. Chest Surg Clin N Am 2000;10(3):569-581.

  38. Suntharalingam M, Sonett JR, Haas ML, Doyle LA, Hausner PF, Scheutz J, Krasna MJ. The use of concurrent chemotherapy with high-dose radiation prior to surgical resection in patients presenting with apical sulcus tumors. Ca J Sci Am 2000;6(6):365-371.

  39. Suntharalingam M, Haas M, Conley BA, Egorin MJ, Levy SG, Herman JM, Jacobs MC, Gray WC, Ord RA, Aisner J, Van Echo DA. Radiation therapy with concurrent weekly, carboplatin and paclitaxel in advanced stage unresectable squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2000;47(1):49-56.

  40. Li XA, Wang R, Yu CX, Suntharalingam M. Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques. Int J Radiat Oncol Biol Phys 2000;46(4):1043-1049.

  41. Park SH, Gray WC, Hernandez I, Jacobs MC, Ord RA, Suntharalingam M, Van Echo DA, Wu S, Conley BA. A phase i trial of all-trans retinoic acid (ATRA) in patients with treated head and neck squamous cell carcinoma. Clin Cancer Res 2000;6(3):847-854.

back to top


This page was last updated on: August 9, 2007.

For More Information